Titan Biotech Limited (TITAN BIOTECH LTD.) aksje

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; and brown rice protein, milk protein, protein hydrolysate, bovine cartilage extract, L-glutathione, cow colostrum powder, collagen peptides, whey protein, sodium caseinate, chondroitin sulphate, and hyaluronic acid. The company also provides coenzyme Q10, glucosamine KCL/HCL, methyl sulfonyl methane, chelated minerals, and peptone; OX bile extract, cholic acid, cerebroprotein hydrolysate, and iron protein succinylate; medicinal yeast and brewer yeast protein; and animal nutrition comprising mannan oligosaccharide, amino chelated mineral, sodium and calcium butyrate, sodium and calcium propionate, protein hydrolysate, and active dry yeast. In addition, it offers liver, meat, malt, and yeast extract. Its products are used in the pharmaceuticals, nutraceuticals, food and beverages, biotechnology and fermentation, cosmetics, veterinary and animal feed, agriculture industries, and microbiology and plant tissue culture media fields. The company also exports its products. Titan Biotech Limited was incorporated in 1992 and is based in New Delhi, India.